Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

ADM Diagnostics LLC (AKA: ADMdx)
Profile last edited on: 10/11/2022      CAGE: 5XWA1      UEI: RM7GK4PLCXK9

Business Identifier: Cutting edge analysis of brain images enabling disease diagnosis
Year Founded
2010
First Award
2011
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

555 Skokie Boulevard Suite 500
Northbrook, IL 6002
   (847) 707-0370
   alukic@admdx.com
   www.admdx.com
Location: Single
Congr. District: 10
County: Cook

Public Profile

Specializing in brain image analysis to enable diagnosis, prognosis, and drug effect detection for Alzheimer's disease and various other forms of dementia, ADMdx provides pharmaceutical companies with powerful information to improve clinical trial success. The firm also provides image data analysis and full CNS imaging study services with structural MRI, amyloid PET, tau PET, FDG PET, ASL, fMRI BOLD, and DTI. Firm also developing diagnostic products to enable early, accurate disease detection supporting optimal patient care.

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
2
Conversion Rate
66.67%
Phase I Dollars
$582,705
Phase II Dollars
$1,979,665
Total Awarded
$2,562,370

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 2 NIH $2,166,587
Project Title: Multi-modal machine learning detection and tracking of traumatic brain injury neurodegeneration and its differentiation from Alzheimer's disease
2018 1 NIH $224,796
Project Title: Alzheimer's Amyloid and Tau Pathology Staging and Clinical Impact Prediction Using Multi-Modal Mri Pattern Classification
2016 2 NSF $1,084,458
Project Title: Early and Specific Dementia Diagnosis Using Imaging and Pattern Classification Software

Key People / Management

  Dawn C Matthews -- President; Chief Executive Officer

  Debra Bartel -- Director of Quality

  Ana S Lukic -- VP R&D

  Stephen C Strother -- Vice President; Chief Science Officer

  Miles N Wernick -- Vice President; Chief Technology Officer

Company News

Sep 30 2014
ADM Diagnostics Invited to White House for BRAIN Initiative Conference.